Pharmaceutical companies are accelerating the transformation of traditional production models to achieve cost reduction and efficiency increase!

【Pharmaceutical Network Industry News】As a private production industry, the cost and consequent price of pharmaceuticals are closely related
to the majority of patients.
Over the years, the price of medicinal materials and labor costs have risen, and how to let the people use high-quality and low-cost drugs has become an urgent problem
for pharmaceutical companies.
In this regard, industry insiders proposed that in order to reduce costs and increase efficiency, we must take technology as a breakthrough to fundamentally improve production efficiency, and under the guidance of this idea, many pharmaceutical companies have opened the road of exploration of
smart production.
Pharmaceutical companies are accelerating the transformation of traditional production models to achieve cost reduction and efficiency increase! (Image source: Pharmaceutical Network) Taking Tasly as an example, due to the particularity of the dosage form of Chinese medicine drop pills, it has not been available in the industry and even internationally, with mature and stable performance and complete sets of advanced equipment, so the lack of equipment level has long become a bottleneck problem
restricting the production and manufacturing of drop pills.
Facing pressure, Tasly independently developed key equipment and created a fifth-generation shot drop machine with high-speed jet high-frequency vibration drip technology to solve technical problems
in production.
It is understood that the equipment greatly reduces the generation of sticky pellets and free pellets by combining high-speed vibration and cryogenic technology, and the integrated implementation of the process control system of online detection technology solves the problems
of online detection of material properties, process status process monitoring, and real-time control of equipment performance.
In the first half of the year, after nearly a year of design and debugging with the technical team of Hubei Mobile Wuhan Branch, Ma Yinglong created a 5G fully connected traditional Chinese medicine product production line, allowing Ma Yinglong Musk Hemorrhoid Ointment, Musk Hemorrhoid Suppository and other products to achieve fully automatic production and full-process tracking
.
In this production line, the processes of tube, filling, sorting, cartoning, online detection, packaging, automatic transfer and other processes are completed in one go, and the production line can produce 180 hemorrhoid ointments
per minute.
In addition to being more efficient, but also reducing manpower input, according to reports, an ointment production line used to need to be equipped with 20 workers, now reduced to 8, mainly to do production line feeding and product quality inspection work, the main process of the production line has been "wrapped"
by automation equipment.
In addition, Huason Pharmaceutical has always adhered to intelligent development and is transforming
into a "smart factory" through intelligent and efficient methods.
According to reports, the fifth phase of the new GMP production base project of Huason Pharmaceutical covers an area of nearly 100,000 square meters, with 22 drug GMP production lines, including powder needles with sterile preparations, lyophilized powder injections, oral preparation tablets, capsules, etc.
, and at the same time has a fully automatic intelligent Chinese medicine extraction production line and a modern warehousing and logistics center, etc.
, and will fully implement MES, BMS, EMS, WMS and other artificial intelligence systems
。 In the future, Huason Pharmaceutical said that it will continue to take intelligent manufacturing as the traction, deepen the construction of "smart factory", continuously improve comprehensive production capacity, product market competitiveness and equipment technology, and strive to achieve full coverage of
"unmanned workshop".
It can be seen from the above that under the background of the country's strengthening of drug supervision and the structural adjustment of the pharmaceutical industry, pharmaceutical companies have generally recognized the importance of
smart production and digital construction.
With the integration and development of technology, the application of cloud computing, big data, industrial Internet and artificial intelligence in the pharmaceutical industry is gradually maturing, and some enterprises are taking the lead in trying, and the intelligent transformation of traditional Chinese medicine raw material extraction, sterile powder injection and preparation production, packaging and logistics is constantly making new breakthroughs
.
The industry expects that with the development of science and technology, intelligent manufacturing will help pharmaceutical companies activate the "development code", through automated, intelligent, information-based production and testing equipment, to help pharmaceutical companies further improve production efficiency, reduce manual input, and achieve traceability, to ensure that traditional Chinese medicine products are more stable and controllable
.
It is worth mentioning that in the pharmaceutical industry to accelerate the transformation of the traditional production mode of traditional Chinese medicine, the industry believes that intelligent pharmaceutical equipment will also have great prospects
.
It is understood that at present, the research and development of enterprises such as Dongfulong, Chutian Technology and Canaan Technology has been steadily progressing
in product intelligence.
Among them, some enterprises are still moving
towards a variety of intelligent overall solution providers.
In general, with the deepening of the national strategy of new infrastructure, the application of emerging technologies such as 5G, big data, and artificial intelligence is more extensive, and the pharmaceutical industry has become one of the most representative areas in terms of
intelligent manufacturing technology and concept application.
In the future, the industry expects that while intelligent manufacturing technology empowers the high-quality development of pharmaceutical companies, it will further help pharmaceutical companies to achieve production mode reform, improve management and operation efficiency, and reduce costs
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
to anyone.